Company: WCT
Filing Date: 2025-12-05
Form Type: 424B3
Source: 0001213900-25-118563
Chunk: 53

Company: Wellchange Holdings Co Ltd
Filing Date: 2025-12-05
Form: 424B3
Chunk 53
---
onomy. The United States may impose the same tariffs and other trade restrictions on exports from Hong Kong that it places
on goods from Mainland China. These and other recent actions may represent an escalation in political and trade tensions involving the
U.S., China and Hong Kong, which could potentially harm our business.

Our revenue is susceptible to ongoing incidents
or factors which affect the stability of the social, economic and political conditions in Hong Kong. Any drastic events may adversely
affect our Operating Subsidiary’s business operations. Such adverse events may include changes in economic conditions and regulatory
environment, social and/or political conditions, civil disturbance, or disobedience, as well as significant natural disasters. Given the
relatively small geographical size of Hong Kong, any of such incidents may have a widespread effect on our Operating Subsidiary’s
business operations, which could in turn, adversely and materially affect our business, results of operations and financial condition.
It is difficult to predict the full impact of the HKAA on Hong Kong and companies with operations in Hong Kong like us. Furthermore,
legislative or administrative actions in respect of China-U.S. relations could cause investor uncertainty for affected issuers, including
us, and the market price of our Class A Ordinary Shares could be adversely affected.

<div align='center'>22</div>

If we become subject to the recent scrutiny, criticism, and negative publicity involving U.S.-listed China-based companies, we may have to expend significant resources to investigate and/or defend the matter, which could harm our business operations, this offering, and our reputation and could result in a loss of your investment in our Class A Ordinary Shares, in particular, if such matter cannot be addressed and resolved favorably.

During the last several years, U.S.-listed
companies that have substantially all of their operations in China have been the subject of intense scrutiny by investors, financial commentators,
and regulatory agencies. Much of the scrutiny has centered on financial and accounting irregularities and mistakes, lack of effective
internal controls over financial reporting, and, in many cases, allegations of fraud. As a result of the scrutiny, the stocks of many
U.S.-listed Chinese companies that have been the subject of such scrutiny have sharply decreased in value. Many of these companies are
now subject to shareholder lawsuits and/or SEC enforcement actions that are conducting internal and/or external investigations into the
allegations.

If we become the subject of any such scrutiny,
whether any allegations are true or not, we may have to expend significant resources